Friday, April 30, 2021

Microbiology & Bacterial Culture for Industrial Testing Market Size Is Estimated To Reach $8.0 Billion By 2025

The global microbiology & bacterial culture for industrial (food, water, bioenergy) testing market size is expected to reach USD 8.0 billion by 2025, according to a new report by Grand View Research, Inc. Growing concern pertaining to the safety of feed supply provided to livestock is recognized as a high impact rendering factor for growth. The use of microorganisms for enhancing bioenergy reproducibility is expected to gain ground in the future microbiology & bacterial culture media & reagent market. This anticipated growth is attributed to the ongoing research and studies to enhance the application of microbial cell culture in biofuel production. 

In addition, growing knowledge pertaining to the significance of bacteria in agriculture and industrial applications is expected to positively influence the progress of the microbial cell culture market for agricultural research. Microbial testing to verify cleanliness or infestation of any pathogen in swab samples from a factory helps maintain the factory environment. Microbial tests, as verification of finished products, are required for product authorization. Microbiology food testing at various stages of development is found to serve as a high impact rendering driver.

In addition, various countries are establishing risk management strategies that include new quality control criteria as a preventive measure to curb the outbreak of microbial infection. These criteria incorporate sample checking in context to microbial parameters at various stages of production to maintain quality and safety. This is anticipated to directly translate into the growth in revenue for this market at a larger level.

Full Research Report On Microbiology & Bacterial Culture for Industrial Testing Market Visit Here: https://www.grandviewresearch.com/industry-analysis/microbiology-culture-market

Further key findings from the report suggest:

  • Media is estimated to account for the largest revenue share due to the availability of ready-to-use and dehydrated media in customized forms
  • Higher adoption of bacteria in industrial production is attributed to the larger share of bacterial media
  • Bacterial media is anticipated to maintain its dominance over the forecast period as a consequence of higher usage in the industrial bioproduction
  • In 2016, food testing was the largest revenue grossing segment of the applications of microbiology culture media and reagents
  • Large application of these products for food and animal feed testing in order to ensure the quality of end product
  • Animal feed testing is anticipated to showcase lucrative growth over the study period due to escalation in the outbreak of animal diseases caused due to the consumption of contaminated feed
  • North American region holds a larger share in terms of revenue. A fair share can be credited to the innovative technology available for processing media and organisms required for bio-production
  • The industry in Asia Pacific is projected to exhibit potential progress in the coming years as a consequence of various developments across major economies, especially in the processed food industry
  • Lately, many multinational companies have shown huge interest in this region by investing heavily in setting up new facilities and promoting distributor networks to meet demand
  • Key players operating include Bio-Rad Laboratories, Inc., bioMérieux SA, Thermo Fisher Scientific, Inc., Merck KGaA, Neogen Corporation, HiMedia Laboratories, Eiken Chemical Co., Ltd.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/microbiology-culture-market/request/rs1

Grand View Research has segmented the global microbiology & bacterial culture for the industrial testing market on the basis of consumables, application, and region:

Consumables Outlook (Revenue, USD Million; 2014 - 2025)

  • Media
    • Bacterial
    • Fungi & Algae
    • Others
  • Reagents
    • Bacterial
    • Others
  • Sera

Application Outlook (Revenue, USD Million; 2014 - 2025)

  • Food & Water Testing
    • Food
    • Animal Feed
    • Water Testing
  • Bioenergy & Agricultural Research
  • Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The U.K.
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
  • Middle East & Africa
    • South Africa

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Intrapartum Monitoring Devices Market Size Is Predicted To Reach $2.83 Billion By 2025

The global intrapartum monitoring devices market is expected to reach USD 2.83 billion by 2025, according to a new report by Grand View Research, Inc. The rising occurrences of preterm birth are resulting in increased infant mortality. The mortality rates differ across the globe, owing to the disparities of income, and lack of access to appropriate maternal care facilities in different regions. The regions with larger lower income groups face the highest infant mortality rates due to inadequate availability of obstetric monitoring and other infant care facilities. Effective maternal and postnatal care can help save more than 3 quarters of the premature babies.

According to the reports of WHO, annually 15.0 million infants are born premature. This number has been observed to be on a rise in the past few years. There are multiple causes for premature deliveries, such as high blood pressure, chronic conditions, infections, multiple pregnancies, early induction of labor. Hence, propelling the need for obstetric devices across the globe.

Rising awareness regarding availability of screening and monitoring procedures, growing prevalence of obesity & Gestational   Diabetes Mellitus (GDM) and increasing demand for improved intrapartum devices are expected to propel the market over the forecast period. 

Full Research Report On Intrapartum Monitoring Devices Market Visit Here: https://www.grandviewresearch.com/industry-analysis/intrapartum-monitors-market

Further key findings from the study suggest:

  • The growing prevalence of obesity, rising preterm birth rate and increasing need for critical obstetric care is primarily driving the market growth
  • The electrodes dominated the market, owing to their affordability, higher adoption volume and repeat purchase.
  • The monitors segment is expected to exhibit fastest growth over the forecast period owing to the technological advancements.
  • North America dominated the market in 2016, owing to rising prevalence of obesity and diabetes, various government initiatives creating awareness regarding rising incidences of preterm births, availability of monitoring test options, and highly developed healthcare infrastructure.
  • Constant rise in the cases of preterm births and infant mortality rates are observed in Asia Pacific. Thus, this region is expected to witness a rapid growth during the forecast period.
  • The key players of the market include Analogic Corporation, GE Healthcare, Koninklijke Philips N.V.; Medtronic plc; CooperSurgical, Inc.; Stryker, and Olympus Corporation.
  • These players hold a strong position in market with their strategic initiatives such as mergers and acquisitions, partnerships with small/local players to expand their geographic foothold and widening of product portfolio by sharing the technology and products.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/intrapartum-monitors-market/request/rs1

Grand View Research has segmented the intrapartum monitoring devices market report on the basis of device type and region:

Device Type Outlook (Revenue, USD Million; 2014 - 2025)

  • Monitors
  • Electrodes
    • Fetal Scalp Electrodes
    • Intrauterine Pressure Catheter
    • Transducer for FHR
    • Transducer for Uterine Contractions

Regional Outlook (Revenue, USD Million; 2014 - 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Image-Guided & Robot-Assisted Surgical Procedures Market Size Is Estimated To Reach $5.6 Billion by 2025

The global image-guided and robot-assisted surgical procedures market size is expected to reach USD 5.6 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 14.6% over the forecast period. An increasing number of complex surgeries, trauma cases, and rapid technological advancements in image-guided robots are expected to propel revenue growth in this market.

Surgical procedures have witnessed a transformation due to technological advancements such as microscopic cameras, three-dimensional (3D) imaging, motion sensors, and remote navigation and robotic catheter control systems in image-guided robots. This, in turn, has enhanced surgical outcomes. The introduction of surgical robots is another factor influencing overall positive health outcomes owing to reduced surgical time and errors. Da Vinci Surgical robot is the most widely used system for complex surgeries. It is accompanied by a computer-enhanced system and enhances its capability of performing laparoscopic surgeries.

Urology surgery was the dominant procedure segment of the global image-guided and robot-assisted surgical procedures market with a share of 38% in 2016. Some of the urological surgeries performed by medical robots include prostatectomy, partial nephrectomy, cystectomy, and pyeloplasty. Da Vinci system is also used to perform complex gynecological procedures such as hysterectomy and sacrocolpopexy. Adoption in surgical procedures helps reduce blood loss and recovery period. An increasing number of surgical procedures using Da Vinci system is expected to drive overall market growth in the near future.

North America accounted for the largest share in the global image-guided and robot-assisted surgical procedures market followed by Europe in 2016. The U.S. accounted for 58.8% of the total global market share in 2016 mainly due to higher penetration of robotics and increasing awareness about minimally-invasive surgeries. Developing economies such as Latin America and Middle East & Africa have witnessed lower adoption owing to the existence of price-sensitive end users. Asia Pacific is projected to expand at a CAGR of 16.4% over the forecast period owing to factors such as improving healthcare infrastructure and increasing penetration of image-guided robots. These factors are expected to contribute to regional demand in the near future.

Full Research Report On Image-Guided & Robot-Assisted Surgical Procedures Market Visit Here: https://www.grandviewresearch.com/industry-analysis/image-guided-and-robot-assisted-surgery-market

Further key findings from the report suggest:

  • North America held the largest market share in 2016 due to high investment, increasing demand for robot-assisted surgeries, and adoption of robotics
  • The U.S. was the largest market with 58.8% of the global market share in terms of revenue in 2016
  • Asia Pacific is anticipated to be the fastest-growing market at a CAGR of 16.4% between 2017 and 2025 owing to rising demand and technological advancements
  • Some of the key players in the image-guided and robot-assisted surgical procedures market are Crouse Hospital, St. Vincent, St. Clair Hospital, Northwest Hospital & Medical Center, Atlantic Health System, The Princess Grace Hospital, Apollo Hospitals Enterprise Ltd., Medanta The Medicity, and George Washington University Hospital.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/image-guided-and-robot-assisted-surgery-market/request/rs1

Grand View Research has segmented the global image-guided and robot-assisted surgical procedures market on the basis of specialty type and region:

Image-guided and Robot-assisted Surgical Procedures Specialty Outlook (Revenue, USD, 2014 - 2025)

  • Gynecologic Surgery
  • Urologic Surgery
  • General Surgery
  • Cardiothoracic Surgery
  • Head & Neck Specialties

Image-guided and Robot-assisted Surgical Procedures Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The U.K.
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Thursday, April 29, 2021

CRISPR & Cas Genes Market Size Is Predicted To Reach $4.88 Billion By 2027

The global clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes market size is expected to reach USD 4.88 billion by 2027, expanding at a CAGR of 16.6% from 2020 to 2027, according to a new report by Grand View Research, Inc. Rise in the adoption of CRISPR technology in epigenetics, therapeutics, human germline editing, plant genome editing, and other fields of biotechnology is expected to drive the market.

Presence of a large number of service providers that provide knockout, knock-in, gene repression, gene activation, and other cell line engineering services propel the growth of cell line engineering services. In biomedical applications, genome engineering held the largest revenue share in 2019. Adoption of gene editing techniques for human- and non-human-based genomic engineering is one of the key factors that drive the segment.

The molecular scissor can facilitate the detection of viruses, allowing the development of cost-effective, robust, and rapid point-of-care diagnostics. It allows the detection of viruses at a level of molecular concentration that researchers rarely assess. Sherlock Bioscience estimated that a CRISPR-powered diagnostic test would be available in the future at a reasonable price. In recent times, the most important innovation has been the development of a test for COVID-19.

In March 2020, Mesa Biotech announced FDA authorization for its Accula device, a hand-held COVID-19 diagnostic test. Similarly, in April 2020, CSIR lab announced the development of a paper-strip test for Covid-19 that uses CRISPR-Cas9 to target and identifies the genomic sequences of the virus. Unlike the PCR tests, this test is available at a very low price, USD 6.59 (INR 1 = USD 0.013). Therefore, such initiatives are expected to encourage other players to leverage this crisis and launch novel products.

Full Research Report On CRISPR & Cas Genes Market Visit Here: https://www.grandviewresearch.com/industry-analysis/crispr-associated-cas-genes-market

CRISPR & Cas Genes Market Report Highlights

  • The product segment is anticipated to dominate the market throughout the forecast period. This is attributed to the presence of enhanced individual products that can serve multiple purposes including genome engineering, specific genome cleavage using gRNAs, easy gene knockouts, along with reduced off-target cutting, and increased specificity
  • Cell line engineering services accounted for the largest market share in 2019. The development of this technology has simplified the genome engineering process to a large extent
  • In biomedical applications, genome engineering held the largest revenue share in 2019 as a result of an increase in the adoption of genome editing techniques for modifications in germline and therapeutics development
  • Recent advancements in CRISPR/Cas genome editing allow targeted modification in crops, thereby promising crop improvement and revenue generation in the market
  • A significant number of research studies carried out to develop disease-specific novel therapies and presence of a huge clinical pipeline that integrates the application of this gene-editing technology are expected to boost revenue generation for the biotechnology and pharmaceutical companies segment
  • Asia Pacific is anticipated to witness the fastest growth over the forecast period. China holds a significant position in the CRISPR market and is increasingly exploring genome-editing for the development of medicines. The country has launched several CRISPER-based clinical trials, especially for cancer treatment.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/crispr-associated-cas-genes-market/request/rs1

CRISPR & Cas Genes Market Segmentation

Grand View Research has segmented the global CRISPR and Cas Genes market on the basis of product and service, application, end use, and region:

CRISPR & Cas Genes Product & Service Outlook (Revenue, USD Million, 2016 - 2027)

  • By Product
    • Kits & Enzymes
      • Vector-based Cas
      • DNA-free Cas
    • Libraries
    • Design Tool
    • Antibodies
    • Others
  • By Service
    • Cell Line Engineering
    • gRNA Design
    • Microbial Gene Editing
    • DNA synthesis

CRISPR & Cas Genes Application Outlook (Revenue, USD Million, 2016 - 2027)

  • Biomedical
    • Genome Engineering
    • Disease Model Studies
    • Functional Genomics
    • Epigenetics
    • Others
  • Agricultural

CRISPR & Cas Genes End-use Outlook (Revenue, USD Million, 2016 - 2027)

  • Biotechnology & Pharmaceutical Companies
  • Academics & Government Research Institutes
  • Contract Research Organizations (CROs)

CRISPR & Cas Genes Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia

List of Key Players of CRISPR & CRISPR-Associated (Cas) Genes Market:

  • CRISPR Therapeutics
  • AstraZeneca
  • Addgene
  • Caribou Biosciences, Inc.
  • Cellectis
  • Editas Medicine, Inc.
  • Egenesis
  • F. Hoffmann-La Roche Ltd.
  • Horizon Discovery Group Plc
  • Genscript
  • Danaher Corporation
  • Intellia Therapeutics, Inc.
  • Lonza
  • Merck KGaA
  • New England BioLabs
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Synthego
  • Mammoth Biosciences
  • Inscripta, Inc.
  • Cibus

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Wednesday, April 28, 2021

Adhesion Barrier Market Size Is Projected To Reach $1.2 Billion By 2027

The global adhesion barrier market size is expected to reach USD 1.2 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 7.1% over the forecast period. The key drivers of the market include increasing incidence of cardiovascular diseases coupled with rising cases of post-surgical adhesions. Factors such as increasing healthcare expenditure and rising awareness about post-surgical complications among patients are adding growth to the market. Moreover, increasing number of cancer cases are also adding demand for surgical interventions. According to National Cancer Institute, in 2018, there were approximately 1.7 million new cases of cancer diagnosed in U.S.

Furthermore, increasing geriatric population is also substantially increasing the usage of adhesion barriers as they suffer from various chronic diseases, which require surgery. According to the World Health Organization (WHO), one in four persons living in North America and Europe could be aged 65 or more by 2050. The number of people aged more than 80 years is anticipated to reach 426 million in 2050. Additionally, with rising urbanization and increasing inclination towards healthy lifestyle, more people are expected get involve in various sports activities. Therefore, resulting in increasing sports related injuries, causing rising usage of adhesion barriers.

Full Research Report On Adhesion Barrier Market Visit Here: https://www.grandviewresearch.com/industry-analysis/adhesion-barrier-market

Adhesion Barrier Market Report Highlights

  • North America accounted for the largest share in 2019 owing to favorable reimbursement policies, presence of key players, and government initiatives
  • By product, the synthetic adhesion barriers segment dominated the market in 2019 owing to its high usage in various surgical interventions
  • Based on synthetic adhesion barriers products, the hyaluronic acid segment accounted for the largest market size in 2019 owing to its capacity to attract and hold a vast amount of moisture
  • Based on natural adhesion barriers products, the collagen and protein segment held the largest share in 2019 as it is easy to apply and is resorbable after repair
  • By formulation, the film/mesh segment accounted for the largest size in 2019 owing to its low cost and high usage in various form of surgeries
  • By application, the cardiovascular surgery segment is expected to register the highest CAGR due to rising incidence of heart diseases
  • The leading players present in the market are Sanofi S.A.; Becton Dickinson and Company; Baxter International, Inc.; Johnson & Johnson; Anika Therapeutic, Inc.; FzioMed, Inc.; Mast Biosurgery, Inc.; Innocoll Holdings PLC; and Atrium Medical Corporation (Getinge Group).

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/adhesion-barrier-market/request/rs1

Adhesion Barrier Market Segmentation

Grand View Research has segmented the global adhesion barrier market on the basis of product, formulation, application, and region:

Adhesion Barrier Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Synthetic Adhesion Barriers
    • Hyaluronic acid
    • Regenerated cellulose
    • Polyethylene glycol
    • Others
  • Natural Adhesion Barriers
    • Collagen & Protein
    • Fibrin

Adhesion Barrier Formulation Outlook (Revenue, USD Million, 2016 - 2027)

  • Film/Mesh
  • Gel
  • Liquid

Adhesion Barrier Application Outlook (Revenue, USD Million, 2016 - 2027)

  • Gynecological Surgeries
    • Synthetic
    • Natural
  • Abdominal General Surgeries
    • Synthetic
    • Natural
  • Orthopedic Surgeries
    • Synthetic
    • Natural
  • Cardiovascular Surgeries
    • Synthetic
    • Natural
  • Neurological Surgeries
    • Synthetic
    • Natural
  • Urological Surgeries
    • Synthetic
    • Natural
  • Others
    • Synthetic
    • Natural

Adhesion Barrier Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Switzerland
    • Russia
    • Poland
    • Netherland
    • Greece
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Vietnam
    • New Zealand
    • Malaysia
    • Indonesia
    • Hongkong
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Oman
    • Egypt

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com